Global In-Vitro Colorectal Cancer Screening Tests Market Insights and Forecast to 2028

Report ID: 1240437 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biomarker Tests
        1.2.3 Fecal Occult Blood Tests
        1.2.4 CRC DNA Screening Tests
    1.3 Market by Application
        1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital and Clinics
        1.3.3 Ambulatory
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Perspective (2017-2028)
    2.2 In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
        2.2.1 In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Region (2017-2022)
        2.2.3 In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2023-2028)
    2.3 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
        2.3.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
        2.3.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers
        2.3.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
        2.3.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue
        3.1.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (2017-2022)
        3.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2017-2022)
    3.2 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by In-Vitro Colorectal Cancer Screening Tests Revenue
    3.4 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio
        3.4.1 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Colorectal Cancer Screening Tests Revenue in 2021
    3.5 In-Vitro Colorectal Cancer Screening Tests Key Players Head office and Area Served
    3.6 Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
    3.7 Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Type
    4.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Type (2017-2022)
    4.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2023-2028)
5 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Application
    5.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Application (2017-2022)
    5.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
    6.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
        6.2.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
        6.2.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
        6.2.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
    6.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application
        6.3.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
        6.3.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
        6.3.3 North America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
    6.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
        6.4.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
        6.4.2 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
    7.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type
        7.2.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
        7.2.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
        7.2.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
    7.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application
        7.3.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
        7.3.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
        7.3.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
    7.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country
        7.4.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
        7.4.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
    8.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type
        8.2.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
    8.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application
        8.3.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
    8.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region
        8.4.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
    9.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type
        9.2.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
        9.2.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
        9.2.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
    9.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application
        9.3.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
        9.3.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
        9.3.3 Latin America In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
    9.4 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country
        9.4.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
        9.4.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size (2017-2028)
    10.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type
        10.2.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Type (2017-2028)
    10.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application
        10.3.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Share by Application (2017-2028)
    10.4 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country
        10.4.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Alere(Abbott)
        11.1.1 Alere(Abbott) Company Details
        11.1.2 Alere(Abbott) Business Overview
        11.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Introduction
        11.1.4 Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.1.5 Alere(Abbott) Recent Developments
    11.2 Beckman Coulter
        11.2.1 Beckman Coulter Company Details
        11.2.2 Beckman Coulter Business Overview
        11.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Introduction
        11.2.4 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.2.5 Beckman Coulter Recent Developments
    11.3 Siemens Healthcare
        11.3.1 Siemens Healthcare Company Details
        11.3.2 Siemens Healthcare Business Overview
        11.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Introduction
        11.3.4 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.3.5 Siemens Healthcare Recent Developments
    11.4 Eiken Chemical
        11.4.1 Eiken Chemical Company Details
        11.4.2 Eiken Chemical Business Overview
        11.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Introduction
        11.4.4 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.4.5 Eiken Chemical Recent Developments
    11.5 Hitachi Chemical (Kyowa Medex)
        11.5.1 Hitachi Chemical (Kyowa Medex) Company Details
        11.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
        11.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Introduction
        11.5.4 Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
    11.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
        11.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
        11.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
        11.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Introduction
        11.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
    11.7 Sysmex
        11.7.1 Sysmex Company Details
        11.7.2 Sysmex Business Overview
        11.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Introduction
        11.7.4 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.7.5 Sysmex Recent Developments
    11.8 QIAGEN
        11.8.1 QIAGEN Company Details
        11.8.2 QIAGEN Business Overview
        11.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Introduction
        11.8.4 QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.8.5 QIAGEN Recent Developments
    11.9 R-Biopharm
        11.9.1 R-Biopharm Company Details
        11.9.2 R-Biopharm Business Overview
        11.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Introduction
        11.9.4 R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.9.5 R-Biopharm Recent Developments
    11.10 Immunostics
        11.10.1 Immunostics Company Details
        11.10.2 Immunostics Business Overview
        11.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Introduction
        11.10.4 Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
        11.10.5 Immunostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biomarker Tests
    Table 3. Key Players of Fecal Occult Blood Tests
    Table 4. Key Players of CRC DNA Screening Tests
    Table 5. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2017-2022)
    Table 9. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region (2023-2028)
    Table 11. In-Vitro Colorectal Cancer Screening Tests Market Trends
    Table 12. In-Vitro Colorectal Cancer Screening Tests Market Drivers
    Table 13. In-Vitro Colorectal Cancer Screening Tests Market Challenges
    Table 14. In-Vitro Colorectal Cancer Screening Tests Market Restraints
    Table 15. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Players (2017-2022)
    Table 17. Global Top In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2021)
    Table 18. Ranking of Global Top In-Vitro Colorectal Cancer Screening Tests Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players In-Vitro Colorectal Cancer Screening Tests Product Solution and Service
    Table 22. Date of Enter into In-Vitro Colorectal Cancer Screening Tests Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2017-2022)
    Table 26. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2023-2028)
    Table 28. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2017-2022)
    Table 30. Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Application (2023-2028)
    Table 32. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Alere(Abbott) Company Details
    Table 63. Alere(Abbott) Business Overview
    Table 64. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product
    Table 65. Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 66. Alere(Abbott) Recent Developments
    Table 67. Beckman Coulter Company Details
    Table 68. Beckman Coulter Business Overview
    Table 69. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product
    Table 70. Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 71. Beckman Coulter Recent Developments
    Table 72. Siemens Healthcare Company Details
    Table 73. Siemens Healthcare Business Overview
    Table 74. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product
    Table 75. Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 76. Siemens Healthcare Recent Developments
    Table 77. Eiken Chemical Company Details
    Table 78. Eiken Chemical Business Overview
    Table 79. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product
    Table 80. Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 81. Eiken Chemical Recent Developments
    Table 82. Hitachi Chemical (Kyowa Medex) Company Details
    Table 83. Hitachi Chemical (Kyowa Medex) Business Overview
    Table 84. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product
    Table 85. Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 86. Hitachi Chemical (Kyowa Medex) Recent Developments
    Table 87. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
    Table 88. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
    Table 89. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product
    Table 90. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 91. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
    Table 92. Sysmex Company Details
    Table 93. Sysmex Business Overview
    Table 94. Sysmex In-Vitro Colorectal Cancer Screening Tests Product
    Table 95. Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 96. Sysmex Recent Developments
    Table 97. QIAGEN Company Details
    Table 98. QIAGEN Business Overview
    Table 99. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product
    Table 100. QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 101. QIAGEN Recent Developments
    Table 102. R-Biopharm Company Details
    Table 103. R-Biopharm Business Overview
    Table 104. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product
    Table 105. R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 106. R-Biopharm Recent Developments
    Table 107. Immunostics Company Details
    Table 108. Immunostics Business Overview
    Table 109. Immunostics In-Vitro Colorectal Cancer Screening Tests Product
    Table 110. Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022) & (US$ Million)
    Table 111. Immunostics Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Type: 2021 VS 2028
    Figure 2. Biomarker Tests Features
    Figure 3. Fecal Occult Blood Tests Features
    Figure 4. CRC DNA Screening Tests Features
    Figure 5. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Application: 2021 VS 2028
    Figure 6. Hospital and Clinics Case Studies
    Figure 7. Ambulatory Case Studies
    Figure 8. Home Care Case Studies
    Figure 9. In-Vitro Colorectal Cancer Screening Tests Report Years Considered
    Figure 10. Global In-Vitro Colorectal Cancer Screening Tests Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global In-Vitro Colorectal Cancer Screening Tests Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Region: 2021 VS 2028
    Figure 13. Global In-Vitro Colorectal Cancer Screening Tests Market Share by Players in 2021
    Figure 14. Global Top In-Vitro Colorectal Cancer Screening Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Colorectal Cancer Screening Tests Revenue in 2021
    Figure 16. North America In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
    Figure 18. North America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
    Figure 19. North America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
    Figure 20. United States In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
    Figure 24. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
    Figure 25. Europe In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
    Figure 26. Germany In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific In-Vitro Colorectal Cancer Screening Tests Market Size Share by Region (2017-2028)
    Figure 36. China In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
    Figure 46. Mexico In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Size Share by Country (2017-2028)
    Figure 52. Turkey In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Alere(Abbott) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 56. Beckman Coulter Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 57. Siemens Healthcare Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 58. Eiken Chemical Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 59. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 60. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 61. Sysmex Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 62. QIAGEN Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 63. R-Biopharm Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 64. Immunostics Revenue Growth Rate in In-Vitro Colorectal Cancer Screening Tests Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Frequently Asked Questions
In-Vitro Colorectal Cancer Screening Tests report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In-Vitro Colorectal Cancer Screening Tests report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In-Vitro Colorectal Cancer Screening Tests report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

ASA Copolymers

ASA Copolymers market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Organ-on-Chip

Organ-on-Chip market is segmented by Type and by End Users. Players, stakeholders, and other part ... Read More

Explosion Panels

Explosion Panels market is segmented by Type and by Application. Players, stakeholders, and other ... Read More